Lv1
18 积分 2025-03-03 加入
IL4I1+ macrophages drive hepatocellular carcinoma progression by responding to biomechanical cues
2个月前
已完结
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
3个月前
已完结
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
3个月前
已完结
Streptococcus anginosus -derived methionine promotes gastric cancer progression
6个月前
已关闭
Pseudomonas aeruginosa exacerbates bladder cancer progression by activating cancer-driven immunosuppression
6个月前
已完结
Targeting Sialylation Enhances the Therapeutic Efficacy of the Nectin-4-Targeted Antibody-Drug Conjugate Enfortumab Vedotin in Bladder Cancer
7个月前
已完结
皖公网安备34019202002308
